Effect of Significant Two-Vessel Versus One-Vessel Coronary Artery Stenosis on Myocardial Contrast Defects Observed With Intermittent Harmonic Imaging After Intravenous Contrast Injection During Dobutamine Stress Echocardiography  by Porter, Thomas R et al.
Effect of Significant Two-Vessel Versus One-Vessel Coronary Artery
Stenosis on Myocardial Contrast Defects Observed With Intermittent
Harmonic Imaging After Intravenous Contrast Injection During
Dobutamine Stress Echocardiography
THOMAS R. PORTER, MD, FACC, SHOUPING LI, MD, KAREN KILZER, RT,
UBEYDULLAH DELIGONUL, MD
Omaha, Nebraska
Objectives. We sought to determine the effect of multivessel as
opposed to single-vessel coronary artery stenosis on myocardial
contrast defects observed with intermittent harmonic imaging and
intravenous perfluorocarbon-exposed sonicated dextrose albumin
contrast injection.
Background. Intermittent harmonic imaging has permitted the
detection of myocardial perfusion abnormalities with an intrave-
nous ultrasound contrast agent. The effect of multivessel disease
on inducibility of these perfusion abnormalities is unknown.
Methods. In 10 dogs, intravenous injections of contrast agent
were given at rest and during dobutamine stress echocardiogra-
phy when a single coronary artery stenosis was present (>250%
diameter by quantitative angiography) and again when a second
stenosis (range 44% to 92% diameter) was present in the vessel
supplying the adjacent perfusion bed. The peak myocardial con-
trast was visually and quantitatively assessed in the mid and
lateral regions of the perfusion bed of the first stenosis (original
stenosis zone) in the presence of one- and two-vessel stenosis.
Results. Peak myocardial contrast defects in both the mid and
lateral segments of the original stenosis zone during dobutamine
stress echocardiography was significantly lower when two-vessel
stenosis was present (p 5 0.015), especially in the lateral segment.
The spatial extent of the perfusion defect in the original stenosis
zone risk area increased significantly when two-vessel stenosis
was present, and correlated closely with actual risk area (r 5
0.99). Previous total occlusion followed by reperfusion of the
vessel supplying the original stenosis zone significantly increased
the amount of collateral activity between perfusion beds.
Conclusions. Collateral flow limits the spatial extent of induc-
ible ischemia within the risk area of single-vessel stenosis. Restor-
ing blood flow to one perfusion bed reduces the extent of a
perfusion abnormality that can be induced in an adjacent ste-
nosed bed.
(J Am Coll Cardiol 1997;30:1399–406)
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The myocardial contrast produced with intermittent harmonic
imaging after intravenous perfluorocarbon ultrasound contrast
injection has been shown to correlate with both coronary blood
flow and myocardial blood flow changes (1,2). More recently, it
has been shown to be capable of quantifying absolute myocar-
dial blood flow (3). These validation studies have primarily
been done in the absence of coronary artery disease (CAD) or
with only single coronary artery narrowing. In a routine clinical
setting, however, noninvasive imaging technicians are often
asked not only to detect whether significant CAD is present,
but also to discriminate between single-vessel and multivessel
CAD. The myocardial contrast produced with intermittent
imaging in an experimental setting of both single-vessel and
multivessel CAD, therefore, may give a better understanding
of how sensitive this technique is in discriminating between
these two settings and how much global myocardial perfusion
is affected by significant coronary artery narrowing in more
than one vessel. The purpose of this study was to compare the
effects of two-vessel versus one-vessel stenosis on the severity
of a contrast defect that can be induced during stress echocar-
diography when using an intravenous ultrasound contrast
agent and intermittent harmonic imaging.
Methods
Preparation of perfluorocarbon-exposed, sonicated dex-
trose albumin. Perfluorocarbon-exposed sonicated dextrose
albumin (PESDA) was prepared similar to previously de-
scribed methods (1). Briefly, 8 ml of perfluorobutane was
hand-agitated with a 3:1 mixture of 5% dextrose and 5%
human albumin. This mixture then underwent electromechan-
ical sonication for 80 s. The mean microbubble size of PESDA
using this method has been shown to be 4.7 6 0.2 mm, with a
mean concentration of 1.3 3 109 microbubbles per milliliter.
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The dose of intravenous PESDA for all comparisons of
myocardial contrast enhancement was 0.0025 ml/kg in seven
dogs, 0.005 ml/kg in two dogs and 0.01 ml/kg in one dog.
Animal preparation. The study involved 10 mongrel dogs.
The entire study was approved by the Institutional Animal
Care and Use Committee and was in compliance with the
“Position of the American Heart Association on Research
Animal Use,” adopted by the Association in November 1984.
Each dog was placed under general anesthesia with intrave-
nous sodium pentobarbital, intubated and placed on a respi-
rator. A left lateral thoracotomy was performed and the heart
was suspended in a pericardial cradle. Two-millimeter transit-
time ultrasound coronary flow cuffs (S-series, Transonics, Inc.)
were placed around the left anterior descending coronary
artery (LAD) and left circumflex coronary artery (LCx) to
monitor coronary blood flow. A 7F pulmonary artery catheter
and a 7F pigtail catheter were used to monitor pulmonary
artery and left ventricular pressures, respectively. Then 2-0 silk
ligatures were placed around the LAD and LCx for subsequent
creation of stenoses. Ultrasound images were obtained using a
harmonic transducer supplied by either Hewlett Packard
(2.0 MHz fundamental frequency) or Advanced Technology
Laboratories (1.7 MHz fundamental frequency). The trans-
ducer was placed in a warm water bath overlying the anterior
surface of the heart and positioned to produce a short-axis
view of the left ventricle at the mid-papillary muscle level. The
region of interest for comparing peak myocardial videointen-
sity (PMVI) was either the midanteroseptal and midseptal
segments (LAD perfusion bed) or midlateral and midposterior
segments (LCx perfusion bed). Intermittent imaging was per-
formed by triggering ultrasound transmission to just one point
every one to three cardiac cycles.
Background-subtracted PMVI from the LAD and LCx
perfusion beds was measured off-line at end-systole from high
fidelity videotape images. Gray-scale software (Tom-Tec Re-
view Station), which quantitates videointensity (0 to 255 scale)
versus time, was used to measure the contrast intensity.
Instrument settings and triggering intervals were kept constant
in each dog for each comparison. The region of interest (;100
square pixels) was placed at the midmyocardial level of each
segment analyzed and kept at this position for comparisons of
PMVI when one- and two-vessel stenoses were present. For
the purpose of analysis, the perfusion bed supplied by the first
stenosis was termed the original stenosis zone (SZ). This SZ was
also subdivided into a middle segment (mid-SZ) and a lateral
segment (lat-SZ) (outer 25% of the risk area). Then PMVI was
measured in each of these regions under baseline conditions
and during dobutamine stress echocardiography. The perfu-
sion bed supplied by the second stenosis was termed the
adjacent perfusion bed (APB).
Measurements of regional wall thickness inside and out-
side the ischemic zone. Regional left ventricular wall thicken-
ing in the SZ and APB was measured at each setting using
videotape analysis of the end-diastolic and end-systolic frames
(defined as the largest and smallest left ventricular chamber
sizes in the cardiac cycle, respectively). The average regional
wall thickness from three equally spaced measurements of
end-diastolic and end-systolic wall thickness within the LAD
and LCx perfusion beds was taken after each intervention.
Creation of one- and two-vessel CAD before and after
abrupt occlusion. In the first six dogs, a 2-0 silk ligature was
first tightened around the LAD (n 5 4) or LCx (n 5 2). As
previously stated, the perfusion bed supplied by this vessel was
called the SZ. Intravenous injections of PESDA were then
administered, and contrast images from intermittent imaging
were transferred to videotape. Conventional (.30 Hz) frame
rate images were also recorded for wall thickening measure-
ments. After these baseline injections, a second stenosis was
then made in the second coronary artery supplying the APB.
Repeat intravenous injections of PESDA were then performed
in the setting of two-vessel stenosis. Coronary blood flow
measurements in both vessels were also recorded with both
one- and two-vessel stenoses.
Coronary angiography was then performed to assess the
severity of stenosis. This was accomplished with a 7F Amplatz
catheter, which was placed into the left main coronary artery
under fluoroscopic guidance for injections (2 to 3 ml) of
radiographic contrast agent. The images from these injections
were stored on cine film and used to confirm angiographic
stenosis severity after reperfusion with an automated border-
detection computer program (ARTREK, ImageComm). The
flow probe was removed before angiography so that both
proximal and distal reference points could be used for quan-
titative angiography. The coronary catheter was used for
calibration. Both percent diameter stenosis and minimal lumen
diameter (MLD) were measured for each stenosis.
After this, incremental dobutamine infusion was performed
starting with 5 mg/kg body weight per min for 7 min and
increasing if needed to 10, 20, 30 and 40 mg/kg per min. Peak
stress was considered present if the heart rate increased by 20
beats/min over baseline levels or a new wall motion abnormal-
ity developed. At peak stress, contrast enhancement with the
same dose of intravenous PESDA as that used for baseline
measurements was repeated using the same triggering interval.
Coronary blood flow from the transit-time flow meters was also
measured in each coronary vessel.
Then, the second stenosis supplying the APB was removed
while the peak dobutamine dose was still at peak infusion.
Abbreviations and Acronyms
APB 5 adjacent perfusion bed
CAD 5 coronary artery disease
LAD 5 left anterior decending coronary artery
lat-SZ 5 lateral segment of stenosis zone
LCx 5 left circumflex coronary artery
Mid-SZ 5 middle segment of stenosis zone
MLD 5 minimal lumen diameter
PESDA 5 perfluorocarbon-exposed sonicated dextrose albumin
PMVI 5 peak myocardial videointensity
SZ-vessel 5 vessel supplying the stenosis zone
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Once coronary flow reached a steady state in this vessel,
contrast enhancement was reassessed with two more intrave-
nous PESDA injections.
In four dogs, this same experimental protocol was per-
formed after 1.6 6 0.9-h occlusion of the vessel supplying the
SZ (SZ-vessel) to assess the effect of previous coronary
occlusion on the amount of collateral recruitment. After
reperfusion, a stenosis ($50% diameter) was again placed in
the SZ-vessel. After intravenous PESDA injections in the
setting of one-vessel stenosis, a second stenosis was placed in
the vessel supplying the APB. After baseline PESDA injec-
tions, dobutamine infusion was initiated up to 10 mg/kg per
min, and contrast injections were repeated with two-vessel and
then one-vessel stenosis as described earlier.
In dogs in which a visually evident contrast defect was
present in the SZ, the defect was planimetered during dobut-
amine stress echocardiography when two vessels were ste-
nosed, and again after the stenosis supplying the APB was
removed. These measurements were compared with the total
spatial extent of the SZ perfusion bed (risk area), which was
determined by injecting intravenous PESDA after total occlu-
sion of the vessel at the end of the experiment. Finally, 40 ml
of 3% Monastral Blue (4) was then administered into the left
atrial appendage, and the dog was subsequently killed. The
heart was excised and sliced in views that corresponded to the
short-axis echocardiographic image. A transparency was over-
laid onto the myocardium for tracing of the myocardial regions
that were stained by Monastral Blue and the areas that were
not stained (area at risk). These risk area measurements were
correlated with the spatial extent of the contrast defect deter-
mined with PESDA during total occlusion of the SZ-vessel.
Triphenyltetrazolium chloride staining was performed in the
four dogs that had prolonged coronary occlusion before per-
forming the one-vessel versus two-vessel study.
Statistical analysis. Peak myocardial videointensities in
the SZ (mid and lateral segments) with two-vessel compared
with one-vessel stenosis during dobutamine stress echocardi-
ography were compared using the paired t test. Analysis of
variance (Student-Newman-Keuls multiple comparisons pro-
cedure) was used to compare PMVI at peak dobutamine stress
echocardiography in the mid and lateral segments of the SZ
during one- and two-vessel stenosis. This was also used to
compare coronary blood flow and wall thickening at peak
dobutamine stress echocardiography in the SZ and APB
during one-vessel and two-vessel CAD.
Comparisons of PMVI in the SZ during dobutamine stress
echocardiography in dogs with two-vessel stenosis and a pre-
vious coronary occlusion compared with those with no previous
occlusion were made using the unpaired t test. This was also
used to compare the SZ-MLDs in dogs that had a visually
evident contrast defect with those of dogs that did not exhibit
a contrast defect. A correlation between the MLD of the
stenosis supplying the APB and the degree of improvement in
myocardial contrast in the lat-SZ after releasing the stenosis
supplying the APB during dobutamine stress echocardiography
was made using the Pearson correlation coefficient. Interob-
server variabilities in PMVI measurements between two inde-
pendent reviewers were also compared using the Pearson
correlation coefficient. Injection to injection variability in
PMVI was also measured with the same coefficient.
Results
The range of MLDs in the SZ-vessel was 0.51 to 1.47 mm
(mean 0.93), whereas the range of percent diameter stenoses
was 50% to 82% (mean 61%). The range of MLDs supplying
the APB was 0.21 to 1.5 mm (mean 0.97). Mean percent
diameter of the vessel supplying the APB was 70 6 11%.
Although the four dogs that were studied after prolonged
coronary ischemia had only a 10 mg/kg per min dose of
dobutamine, they also had a chronotropic response during
dobutamine infusion. The mean heart rate under rest condi-
tions in the six dogs that had studies before coronary occlusion
was 129 6 19 beats/min and increased to 163 6 7 beats/min
during dobutamine stress echocardiography. In the four dogs
that were studied after reperfusion, the rest heart rate was
102 6 18 beats/min and increased to 131 6 16 beats/min during
dobutamine infusion. Left ventricular systolic pressure also
increased significantly from 111 6 15 mm Hg under baseline
conditions to 139 6 28 mm Hg during dobutamine stress
echocardiography in all dogs.
Coronary blood flow and wall thickening responses in the
setting of one-vessel and two-vessel stenoses. Table 1 demon-
strates the changes in wall thickening and coronary blood flow
to both the SZ and APB under rest conditions and during
dobutamine stress echocardiography in the presence of one-
Table 1. Measurements of Peak Myocardial Videointensity, Wall Thickening and Coronary Blood Flow in the Stenosis Zone and Adjacent
Perfusion Bed in the 10 Study Dogs
One-Vessel CAD Two-Vessel CAD
PMVI (U) WT (%) CBF (ml/min) PMVI (U) WT (%) CBF (ml/min)
SZ APB SZ APB SZ APB SZ APB SZ APB SZ APB
Baseline 69 6 21 75 6 31 31 6 8 39 6 14 23 6 13 35 6 16 54 6 32 53 6 28 34 6 16 46 6 12 15 6 9 28 6 13
DSE 78 6 24 79 6 36 40 6 18 56 6 19 28 6 20 61 6 26 72 6 41 47 6 31* 36 6 23 50 6 21 26 6 21 45 6 31
*p , 0.05 by the paired t test compared with one-vessel coronary artery disease in the same regions. Data presented are mean value 6 SD. APB 5 adjacent
perfusion bed; CAD 5 coronary artery disease; CBF 5 coronary blood flow; DSE 5 dobutamine stress echocardiography; PMVI 5 peak myocardial videointensity;
SZ 5 stenosis zone; WT 5 wall thickening.
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and two-vessel stenoses. Coronary blood flow in the vessel
supplying the APB during dobutamine stress echocardiography
in the setting of two-vessel stenosis was 45 6 31 ml/min and
increased significantly to 61 6 26 ml/min when this stenosis
was released (p , 0.05) (Table 1). Release of the stenosis
supplying the APB did not increase anterograde flow in the
SZ-vessel (Table 1), but there was a significant improvement in
PMVI in the lat-SZ, indicating collateral flow from the APB
(see later discussion).
In three of the six dogs studied during dobutamine stress
echocardiography (without previous occlusion), wall thicken-
ing was abnormal (,30%) in the SZ when two-vessel stenosis
was present. When the stenosis supplying the APB was re-
moved, only one dog had abnormal wall thickening. In the four
dogs studied after prolonged coronary occlusion of the SZ,
wall thickening during dobutamine stress echocardiography
was normal ($30%) in all dogs in the setting of two-vessel
stenosis.
PMVI measurements after intravenous contrast injection
with intermittent harmonic imaging in the setting of one-
versus two-vessel stenosis. During dobutamine stress echocar-
diography, PMVI was significantly lower in the mid-SZ and
lat-SZ when a second stenosis was present in the vessel
supplying the APB (Table 1). Table 2 demonstrates the
individual changes in PMVI in the mid-SZ and lat-SZ during
dobutamine stress echocardiography when one- and two-vessel
narrowing was present. In one dog (dog 7, Table 2), baseline
measurements of PMVI in each segment were not obtained
when both one- and two-vessel stenoses were present. In dogs
with .50% diameter stenosis supplying the APB (8 of 10
dogs), the magnitude of the increase in PMVI in the lat-SZ
perfusion bed when going from two-vessel to one-vessel ste-
nosis during dobutamine stress echocardiography was linearly
related to the MLD of the stenosis of the vessel supplying the
APB (r 5 20.85, p , 0.05) (Fig. 1). The increase in PMVI in
the lat-SZ during dobutamine stress echocardiography after
removal of the stenosis supplying the APB was also affected by
the severity of stenosis supplying the original SZ. As can be
seen from Table 2, the greatest increases in PMVI in the lat-SZ
during dobutamine stress echocardiography after removal of
the APB stenosis occurred in dogs that had either a MLD
,1.0 mm supplying the APB or a MLD ,0.70 mm supplying
the SZ. The increases in PMVI in the remaining dogs were of
lesser significance (range 4% to 24%) and were only slightly
higher than injection to injection variability or interobserver
variability (see later discussion).
A significant increase in PMVI during dobutamine stress
echocardiography was also observed in the mid portion of the
Table 2. Individual Peak Myocardial Videointensity Data (in gray scale units) in Middle and Lateral Segments of Original Stenosis Zone and
Adjacent Perfusion Bed in the Presence of One- and Two-Vessel Stenosis During Both Rest and Dobutamine Stress Echocardiography
Dog
No.
One-Vessel CAD Two-Vessel CAD
Rest DSE Rest DSE Angiography
SZ
APB
SZ
APB
SZ
APB
SZ
APB
% DS MLD (mm)
Mid Lat Mid Lat Mid Lat Mid Lat SZ APB SZ APB Setting
1 84 74 147 84 106 52 61 39 68 66 66 19 54 92 1.03 0.21 II
2 33 82 68 70 40 81 21 33 64 64 6 75 65 NA 0.97 NA II
3 44 107 60 40 82 80 98 64 37 8 3 15 82 44 0.69 1.51 II
4 94 62 101 57 43 37 101 40 67 82 37 8 72 63 0.90 1.50 II
5 87 79 63 56 87 165 47 82 111 33 30 94 77 74 0.51 0.94 II
6 70 13 61 62 42 75 25 7 45 42 34 46 50 59 1.47 1.45 II
7 NA NA NA 106 50 61 NA NA NA 106 48 68 50 58 1.21 1.28 CR1II
8 76 52 75 95 53 90 35 22 23 63 44 85 68 57 0.77 1.10 CR1II
9 79 91 60 103 80 48 76 90 25 154 73 21 57 68 0.70 1.04 CR1II
10 58 58 42 103 84 96 22 30 33 100 58 41 52 71 0.92 0.60 CR1II
Mean 69 69 75 78 67 79 54 45 53 72 40 47 63 65 0.92 1.07
SD 21 27 31 24 24 36 32 28 28 41 23* 31 12 13 0.28 0.44
*p , 0.05 by one-way analysis of variance compared with all other segments. DS 5 diameter stenosis; II 5 induced ischemia only; CR1II 5 coronary reperfusion
plus induced ischemia; NA 5 data not available; other abbreviations as in Table 1.
Figure 1. Correlation between MLD in the vessel supplying the APB
and improvement in PMVI during low dose dobutamine echocardiog-
raphy in the lat-SZ after removal of the stenosis supplying the APB.
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risk area of the SZ in five of the 10 dogs after removal of the
APB stenosis. In all five of these dogs, anterograde coronary
blood flow to the SZ decreased during dobutamine stress
echocardiography, whereas coronary blood flow increased or
stayed the same in the dogs that did not exhibit a change in
PMVI in the mid portion of the SZ when the stenosis supplying
the APB was removed.
Differences in peak myocardial contrast in SZ of dogs with
previous occlusion. As can be seen in Table 2, dogs in whom
studies were performed after prolonged coronary occlusion
demonstrated similar responses in the lat-SZ during dobut-
amine stress echocardiography when compared with those that
had comparisons between one-vessel and two-vessel disease
without previous occlusion (dogs 1 to 6) (Table 2). Despite
similar stenosis severity (67 6 15% in the inducible ischemia
only group vs. 60 6 8% in the coronary reperfusion plus
induced ischemia group), PMVI in the mid-SZ and lat-SZ
during two-vessel stenosis was significantly higher during do-
butamine stress echocardiography in the dogs that had previ-
ous occlusion (81 6 37 U in dogs with previous occlusion vs.
41 6 28 U in dogs without previous occlusion) (p , 0.05).
Spatial measurements of contrast defect within SZ during
dobutamine stress echocardiography during one- and two-
vessel stenosis. In six of the dogs, the contrast defect in the SZ
was visually evident by both observers during dobutamine
stress echocardiography and could be spatially measured in the
presence of both one- and two-vessel stenosis (Fig. 2). The
MLD of the SZ-vessel of these six dogs tended to be smaller
than that in the other four dogs in whom a visually evident
defect could not be spatially measured (0.8 6 0.2 mm in those
with a visually evident defect vs. 1.1 6 0.3 mm in those without
a visually evident contrast defect in the SZ during dobutamine
stress echocardiography) (p 5 0.056). In the six dogs with a
visually evident defect, the size of the contrast defect within the
risk area of the SZ increased significantly when a stenosis
supplying the APB was present (Fig. 3), with the increase in
size occurring mainly at the lateral margins of the SZ risk area.
The contrast defect size with two-vessel stenosis at peak
dobutamine stress echocardiography closely approximated to-
tal risk area for the SZ (r 5 0.99, p , 0.005).
Figure 3 is a short-axis image from one dog during dobut-
amine stress echocardiography that demonstrates the effect of
two-vessel stenosis on the size of the contrast defect in the SZ
(LAD in this dog). Figure 4 is a second example where the LCx
was the original stenosis, again showing the marked increase in
size of the contrast defect within the circumflex risk area when
two-vessel stenosis was present during dobutamine stress echo-
cardiography.
There was a close correlation between the risk area deter-
mined by contrast echocardiography during total occlusion of
the coronary artery and Monastral Blue–derived risk area (r 5
0.93, p 5 0.008). In the four dogs that were studied after
coronary reperfusion, the infarct area within the SZ deter-
mined with triphenyltetrazolium chloride was 25 6 14%.
The interobserver variability in PMVI measurements be-
tween two independent observers was 19% (r 5 0.96, p ,
0.005, SE 13 U). Injection to injection variability in PMVI
measurements both at rest and during dobutamine stress
echocardiography (total of 14 comparisons) was 16% (r 5 0.97,
p , 0.001, SE 9 U).
Discussion
Previous experimental investigations studying collateral
blood flow with intracoronary contrast echocardiography have
demonstrated the dynamic interaction between two APBs
when anterograde myocardial blood flow to one of the regions
becomes reduced (5,6). The lateral zone of the risk area in
these studies became highly dependent on collateral blood flow
from the APB when rest anterograde myocardial blood flow
was reduced (5). Other investigators have demonstrated using
intracoronary contrast echocardiography that collateral perfu-
sion in dogs played a role in determining whether recovery of
Figure 2. Examples of changes in the spatial extent of ischemia in the
SZ risk area during dobutamine stress echocardiography when one-
vessel stenosis supplying the SZ was present (1VCAD) and when a
second stenosis supplying an APB was present (2VCAD). II 5 induced
ischemia only; CR 5 coronary occlusion and reperfusion in the SZ
before inducing ischemia; TTC/RS 5 triphenyltetrazolium chloride
infarct size/risk area size.
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function in the infarct zone would occur. More extensive
collateral flow resulted in a smaller infarct size (7). Experimen-
tal studies using radiolabeled microspheres have demonstrated
that a decrease in subendocardial blood flow in the LAD
perfusion bed occurs during acute LCx ischemia (8).
In this study, we demonstrated a similar dynamic interplay
between LAD and LCx perfusion beds during dobutamine
stress echocardiography with intravenous ultrasound contrast
and intermittent harmonic imaging. The size of a dobutamine-
induced contrast defect in the perfusion bed of a vessel that
had a stenosis was influenced by whether there was also a
significant stenosis in the APB. A second coronary stenosis
broadened the lateral extent of the contrast defect in the
original SZ during dobutamine stress echocardiography. There
was a linear relation between the severity of the stenosis
supplying the APB and severity of the contrast defect observed
in the SZ (Fig. 1). When this second stenosis supplying the
APB was removed, the size of the perfusion defect in the
original SZ was reduced and quantitatively resulted in a
significant increase in PMVI in the lateral segment of the SZ
perfusion bed.
Although the increase in PMVI in the original SZ after
removal of the stenosis supplying the APB during dobutamine
stress echocardiography was significantly greater in the lateral
than in the mid segment of the SZ, we also observed an
increase in PMVI in the mid segment in five of the 10 dogs. It
was in these five dogs that coronary blood flow to the SZ
actually decreased during dobutamine infusion, indicating a
functionally more severe stenosis when compared with the
remaining dogs in whom no change in PMVI in the central
segment of SZ occurred after removal of the APB stenosis.
Previous observations have also shown that even central seg-
ments of a perfusion bed can receive flow from adjacent
perfusion beds when anterograde blood flow becomes severely
reduced (5).
Clinical implications of the study. Clinical studies using
intracoronary myocardial contrast echocardiography in humans
have shown that greater collateral flow to the perfusion bed of
an occluded infarct vessel results in lower peak creatine kinase
levels (9) and better recovery of function within the infarct
zone after restoration of anterograde flow (10). These studies
also demonstrated the superiority of contrast echocardiogra-
phy in identifying collateral blood flow when compared with
angiography. Other investigators have demonstrated that con-
Figure 3. Example of a contrast defect within the
LAD perfusion bed (SZ) that was present in one
dog during dobutamine stress echocardiography
when only LAD stenosis was present during
intermittent harmonic imaging (IHI) and when a
second stenosis supplying the LCx was present
(DOB IHI LAD1LCX). Note the marked de-
crease in contrast in the lateral segment of the
LAD perfusion bed (filled circle) when a stenosis
was present in the LCx. The open circle repre-
sents where the midsegment of the LAD perfu-
sion bed was measured in this dog. The planime-
tered areas are the size of the contrast defect
within the LAD perfusion bed. The size of the
risk area is shown in the lower left image.
Figure 4. Example of the change in the size of
the contrast defect within the LCx perfusion
bed during dobutamine (DOB) stress echo-
cardiography when the LCx was the only
stenosis and when the LAD was also stenosed
(right images). The risk area is shown in the
left image. IHI 5 intermittent harmonic im-
aging.
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trast enhancement from collateral blood flow disappears im-
mediately after successful angioplasty of the coronary artery
supplying anterograde flow to the recipient perfusion bed (11).
Although there are differences in the amount of epicardial
and endocardial collateral connections between dogs and
humans (12), the findings of this study may indicate that
collateral flow from APBs reduces the amount of inducible
ischemia that occurs when only one-vessel CAD exists. This
may explain why the sensitivity of stress perfusion imaging
techniques is consistently lower in detecting angiographically
significant single-vessel CAD compared with multivessel dis-
ease (13). In our study, perfusion defects were significantly
larger in the original SZ only when a second stenosis was
present in the APB. This interaction between perfusion beds is
also important to consider when revascularization is being
considered in patients. Even if only one vessel could be
revascularized in a patient with multivessel CAD, it may
improve blood flow to regions outside the distribution of this
vessel during periods of stress.
In our study, we found that dogs with a previous coronary
occlusion had a sustained increase in collateral flow to the SZ
during dobutamine stress echocardiography when compared
with dogs that did not have a previous coronary occlusion.
Previous ischemia may increase collateral flow to this region
and hence reduce the amount of ischemia that can be induced
after reperfusion. This may explain why patients who have a
previous history of angina, even if it occurred just 48 h before
acute myocardial infarction, have less myocardial damage and
a lower complication rate than patients with no antecedent
angina before infarction (14).
Study limitations. One limitation of our study is that the
coronary lesion was a discrete stenosis in an acute setting.
Although this is different from the more chronic and diffuse
development of a coronary stenosis in the human setting, there
is evidence that this dynamic interaction between perfusion
beds may be even more prominent in the chronic setting.
Intermittent ischemia in chronic CAD may elicit release of
growth factors that promote development of coronary collat-
eral vessels (15). Total occlusion of the LAD has been shown
to only minimally affect left ventricular systolic function in
patients with a long history of angina before occlusion (16). It
is therefore likely that the results of this study may only
indicate the minimal impact that collateral vessels play in
preserving blood flow to a perfusion bed with reduced antero-
grade flow reserve.
Second, although an increase in PMVI in the lat-SZ was
observed when going from two- to one-vessel stenosis during
dobutamine stress echocardiography, we could visually identify
a perfusion defect in the SZ in only six of the dogs. One reason
for this is the poor ability of gray-scale imaging, even with
intermittent harmonic imaging, to detect smaller regional
differences in microbubble concentration within the myocar-
dium. This problem was aggravated during two-vessel isch-
emia, because the APB contrast enhancement was also de-
creased. Recent developments in digital processing, such as
subtraction of precontrast images, combined with color-coding
algorithms that allow better visual discrimination of regional
differences in videointensity (17,18), should improve our ability
to detect the spatial extent of ischemia.
Third, the range of videointensity gray scale for the off-line
analysis of myocardial contrast enhancement used in this study
was from 1 to 255. Adding background myocardial videointen-
sity, maximal myocardial videointensity reached 200 U in some
dogs before background subtraction. These higher values may
have been in the nonlinear portion of the videointensity versus
microbubble concentration curve. Other investigators have
shown that the relation between videointensity and bubble
concentration remains linear at the lower end of this scale (19),
and most videointensities within the myocardium in our study
were in this lower range.
Finally, intermittent harmonic imaging with intravenous
ultrasound contrast injection is limited when compared with
selective intracoronary contrast injections, because the former
cannot quantify how much one vessel is supplying in terms of
collateral channels to an adjacent bed. Furthermore, we do not
have knowledge of where the mid and lateral portions of the
risk area are located in a clinical setting. In our study, however,
we could rapidly determine how much restoration of blood
flow to one vessel resulted in improvement in contrast to the
APB. By assessing contrast enhancement before and after
revascularization, intermittent imaging with intravenous con-
trast injection could rapidly and noninvasively identify how
much myocardial blood flow is improved to all perfusion beds
after revascularization of one vessel.
Conclusions. The size and severity of myocardial contrast
defects in one perfusion bed observed with intermittent imag-
ing and intravenous contrast injections during dobutamine
stress echocardiography are significantly affected by the pres-
ence of a stenosis in the APB. In contrast, removing the
stenosis in this APB results in a significant improvement in
perfusion to the original risk area during periods of stress. The
ability of intermittent harmonic imaging to observe these
phenomena must still be tested in a noninvasive transthoracic
setting. Nonetheless, this dynamic interplay between APBs
should be considered when assessing what effect multivessel
CAD has on global myocardial perfusion.
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